Report Detail
COVID-19 Impact on Global Cognition-Enhancing Drugs Market Insights, Forecast to 2026
- RnM3985156 |
- 03 June, 2020 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Cognition-enhancing drugs are purported to improve mental functions such as cognition, memory, intelligence, motivation, attention and concentration.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cognition-Enhancing Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Cognition-Enhancing Drugs industry.
Based on our recent survey, we have several different scenarios about the Cognition-Enhancing Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Cognition-Enhancing Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cognition-Enhancing Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cognition-Enhancing Drugs market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Cognition-Enhancing Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Cognition-Enhancing Drugs market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Cognition-Enhancing Drugs market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Cognition-Enhancing Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cognition-Enhancing Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cognition-Enhancing Drugs market.
The following manufacturers are covered in this report:
Accelerated Intelligence
Cognition Therapeutics
Cogstate
HVMN
Biogen Idec
...
Cognition-Enhancing Drugs Breakdown Data by Type
Oral
Injection
Cognition-Enhancing Drugs Breakdown Data by Application
Hospital Pharmacies
Drug Stores
Retail Pharmacies
1 Study Coverage
- 1.1 Cognition-Enhancing Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Cognition-Enhancing Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Cognition-Enhancing Drugs Market Size Growth Rate by Type
- 1.4.2 Oral
- 1.4.3 Injection
- 1.5 Market by Application
- 1.5.1 Global Cognition-Enhancing Drugs Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Drug Stores
- 1.5.4 Retail Pharmacies
- 1.6 Coronavirus Disease 2019 (Covid-19): Cognition-Enhancing Drugs Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Cognition-Enhancing Drugs Industry
- 1.6.1.1 Cognition-Enhancing Drugs Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Cognition-Enhancing Drugs Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Cognition-Enhancing Drugs Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Cognition-Enhancing Drugs Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Cognition-Enhancing Drugs Market Size Estimates and Forecasts
- 2.1.1 Global Cognition-Enhancing Drugs Revenue 2015-2026
- 2.1.2 Global Cognition-Enhancing Drugs Sales 2015-2026
- 2.2 Cognition-Enhancing Drugs Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Cognition-Enhancing Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Cognition-Enhancing Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cognition-Enhancing Drugs Competitor Landscape by Players
- 3.1 Cognition-Enhancing Drugs Sales by Manufacturers
- 3.1.1 Cognition-Enhancing Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Cognition-Enhancing Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Cognition-Enhancing Drugs Revenue by Manufacturers
- 3.2.1 Cognition-Enhancing Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Cognition-Enhancing Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Cognition-Enhancing Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Cognition-Enhancing Drugs Revenue in 2019
- 3.2.5 Global Cognition-Enhancing Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Cognition-Enhancing Drugs Price by Manufacturers
- 3.4 Cognition-Enhancing Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Cognition-Enhancing Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Cognition-Enhancing Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Cognition-Enhancing Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Cognition-Enhancing Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Cognition-Enhancing Drugs Sales by Type (2015-2020)
- 4.1.2 Global Cognition-Enhancing Drugs Revenue by Type (2015-2020)
- 4.1.3 Cognition-Enhancing Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Cognition-Enhancing Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Cognition-Enhancing Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Cognition-Enhancing Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Cognition-Enhancing Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Cognition-Enhancing Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Cognition-Enhancing Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Cognition-Enhancing Drugs Sales by Application (2015-2020)
- 5.1.2 Global Cognition-Enhancing Drugs Revenue by Application (2015-2020)
- 5.1.3 Cognition-Enhancing Drugs Price by Application (2015-2020)
- 5.2 Cognition-Enhancing Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Cognition-Enhancing Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Cognition-Enhancing Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Cognition-Enhancing Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Cognition-Enhancing Drugs by Country
- 6.1.1 North America Cognition-Enhancing Drugs Sales by Country
- 6.1.2 North America Cognition-Enhancing Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Cognition-Enhancing Drugs Market Facts & Figures by Type
- 6.3 North America Cognition-Enhancing Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Cognition-Enhancing Drugs by Country
- 7.1.1 Europe Cognition-Enhancing Drugs Sales by Country
- 7.1.2 Europe Cognition-Enhancing Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Cognition-Enhancing Drugs Market Facts & Figures by Type
- 7.3 Europe Cognition-Enhancing Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Cognition-Enhancing Drugs by Region
- 8.1.1 Asia Pacific Cognition-Enhancing Drugs Sales by Region
- 8.1.2 Asia Pacific Cognition-Enhancing Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Cognition-Enhancing Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Cognition-Enhancing Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Cognition-Enhancing Drugs by Country
- 9.1.1 Latin America Cognition-Enhancing Drugs Sales by Country
- 9.1.2 Latin America Cognition-Enhancing Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Cognition-Enhancing Drugs Market Facts & Figures by Type
- 9.3 Central & South America Cognition-Enhancing Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Cognition-Enhancing Drugs by Country
- 10.1.1 Middle East and Africa Cognition-Enhancing Drugs Sales by Country
- 10.1.2 Middle East and Africa Cognition-Enhancing Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Cognition-Enhancing Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Cognition-Enhancing Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Accelerated Intelligence
- 11.1.1 Accelerated Intelligence Corporation Information
- 11.1.2 Accelerated Intelligence Description, Business Overview and Total Revenue
- 11.1.3 Accelerated Intelligence Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Accelerated Intelligence Cognition-Enhancing Drugs Products Offered
- 11.1.5 Accelerated Intelligence Recent Development
- 11.2 Cognition Therapeutics
- 11.2.1 Cognition Therapeutics Corporation Information
- 11.2.2 Cognition Therapeutics Description, Business Overview and Total Revenue
- 11.2.3 Cognition Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Cognition Therapeutics Cognition-Enhancing Drugs Products Offered
- 11.2.5 Cognition Therapeutics Recent Development
- 11.3 Cogstate
- 11.3.1 Cogstate Corporation Information
- 11.3.2 Cogstate Description, Business Overview and Total Revenue
- 11.3.3 Cogstate Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Cogstate Cognition-Enhancing Drugs Products Offered
- 11.3.5 Cogstate Recent Development
- 11.4 HVMN
- 11.4.1 HVMN Corporation Information
- 11.4.2 HVMN Description, Business Overview and Total Revenue
- 11.4.3 HVMN Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 HVMN Cognition-Enhancing Drugs Products Offered
- 11.4.5 HVMN Recent Development
- 11.5 Biogen Idec
- 11.5.1 Biogen Idec Corporation Information
- 11.5.2 Biogen Idec Description, Business Overview and Total Revenue
- 11.5.3 Biogen Idec Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Biogen Idec Cognition-Enhancing Drugs Products Offered
- 11.5.5 Biogen Idec Recent Development
- 11.1 Accelerated Intelligence
- 11.1.1 Accelerated Intelligence Corporation Information
- 11.1.2 Accelerated Intelligence Description, Business Overview and Total Revenue
- 11.1.3 Accelerated Intelligence Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Accelerated Intelligence Cognition-Enhancing Drugs Products Offered
- 11.1.5 Accelerated Intelligence Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Cognition-Enhancing Drugs Market Estimates and Projections by Region
- 12.1.1 Global Cognition-Enhancing Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Cognition-Enhancing Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Cognition-Enhancing Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Cognition-Enhancing Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Cognition-Enhancing Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Cognition-Enhancing Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Cognition-Enhancing Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Cognition-Enhancing Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Cognition-Enhancing Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Cognition-Enhancing Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Cognition-Enhancing Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Cognition-Enhancing Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Cognition-Enhancing Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Cognition-Enhancing Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Cognition-Enhancing Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Cognition-Enhancing Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Cognition-Enhancing Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Cognition-Enhancing Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Cognition-Enhancing Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Cognition-Enhancing Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Cognition-Enhancing Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Cognition-Enhancing Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Cognition-Enhancing Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Cognition-Enhancing Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Cognition-Enhancing Drugs. Industry analysis & Market Report on COVID-19 Impact on Global Cognition-Enhancing Drugs is a syndicated market report, published as COVID-19 Impact on Global Cognition-Enhancing Drugs Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Cognition-Enhancing Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
